Facebook
Britain's News Portal
Around The Clock
BREAKING
Loading latest headlines…

King's College Hospital Trials AI-Powered Tech for Vascular Disease Diagnosis

King's College Hospital is trialling an innovative AI-powered system designed to enhance the diagnosis of peripheral arterial disease (PAD). This new technology aims to improve patient outcomes by providing quicker, more accurate assessments.

  • King's College Hospital is evaluating a new AI-powered diagnostic system for peripheral arterial disease (PAD).
  • The technology, developed by Cambridge Vascular Imaging Ltd, uses AI to analyse ultrasound scans.
  • It aims to provide faster, more accurate measurements of blood vessel blockages.
  • Current diagnostic methods can be time-consuming and prone to variability.
  • Successful trials could lead to earlier intervention and improved patient care across the NHS.

A groundbreaking AI system that could transform how doctors diagnose a potentially serious circulation condition affecting one in five people over 60 is being trialled at King's College Hospital NHS Foundation Trust. The innovative technology aims to detect peripheral arterial disease (PAD) more quickly and accurately than current methods, potentially preventing life-changing complications for thousands of patients.

Peripheral arterial disease occurs when narrowed arteries reduce blood flow to the limbs, typically the legs. According to the British Heart Foundation, this condition affects around 1 in 5 people over 60 in the UK. Without proper treatment, PAD can progress to cause chronic pain, non-healing ulcers, and in the most severe cases, may require amputation. The good news is that early diagnosis and treatment can significantly improve outcomes and quality of life.

Currently, diagnosing PAD relies on manual measurements from ultrasound scans, a process that can be time-consuming and may vary depending on the sonographer's experience. The new AI system, developed by Cambridge Vascular Imaging Ltd, automates and standardises these measurements, providing doctors with more consistent and objective data. The artificial intelligence can analyse complex details within ultrasound images, potentially spotting subtle changes that might otherwise be missed.

For patients, this could mean faster access to treatment. Earlier diagnosis allows doctors to begin appropriate care sooner, which may reduce the risk of serious complications and help maintain mobility and independence. From an NHS perspective, the technology could increase efficiency in vascular clinics, freeing up valuable clinical time and improving patient flow through the system.

Vascular diseases like PAD place considerable demand on NHS resources. This trial represents an important step towards better managing these conditions across the UK. If successful at King's College Hospital, the technology could be rolled out to other NHS trusts, providing a standardised, advanced approach to PAD diagnosis nationwide.

Anyone concerned about circulation problems - such as leg pain when walking, slow-healing wounds, or cold feet - should speak to their GP. For urgent non-emergency health concerns, contact NHS 111. Remember, early detection and treatment of vascular conditions can make a significant difference to long-term health outcomes.

Why this matters: This trial could lead to faster, more accurate diagnoses of peripheral arterial disease for thousands of UK patients, potentially preventing severe complications and improving NHS efficiency.

What this means for you: NHS patients with circulation problems could benefit from faster, more accurate diagnoses as this AI technology reduces waiting times for vascular assessments. If successful, the system may be rolled out across other NHS trusts, potentially shortening the time between GP referrals and specialist diagnosis. Earlier detection of peripheral arterial disease could prevent more serious complications requiring emergency treatment.

Related Articles

Get the news that matters.

Join thousands of readers getting the best of British news straight to their inbox.